• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压急症的管理

Management of hypertensive crises.

作者信息

Feldstein Carlos

机构信息

Hypertension Program, Hospital de Clinicas José de San Martín, Buenos Aires University and Instituto Universitario de Ciencias de la Salud, Buenos Aires, Argentina.

出版信息

Am J Ther. 2007 Mar-Apr;14(2):135-9. doi: 10.1097/01.pap.0000249908.55361.de.

DOI:10.1097/01.pap.0000249908.55361.de
PMID:17414580
Abstract

Hypertensive emergencies are life-threatening conditions because their course is complicated with acute target organ damage. They can present with neurological, renal, cardiovascular, microangiopathic hemolytic anemia, and obstetric complications. After diagnosis, they require the immediate reduction of blood pressure (in <1 hour) with intravenous drugs such as sodium nitroprusside, administered in an intensive care unit. These patients present with a mean arterial pressure >140 mm Hg and grade III to IV retinopathy. Only occasionally do they have hypertensive encephalopathy, reflecting cerebral hyperperfusion, loss of autoregulation, and disruption of the blood-brain barrier. In hypertensive emergencies, blood pressure should be reduced about 10% during the first hour and another 15% gradually over the next 2 to 3 hours to prevent cerebral hypoperfusion. The exception to this management strategy is aortic dissection, for which the target is systolic blood pressure <120 mm Hg after 20 minutes. Oral antihypertensive therapy can usually be instituted after 6 to 12 hours of parenteral therapy. Hypertensive urgencies are severe elevations of blood pressure without evidence of acute and progressive dysfunction of target organs. They demand adequate control of blood pressure within 24 hours to several days with use of orally administered agents. The purpose of this review is to provide a rational approach to hypertensive crisis management.

摘要

高血压急症是危及生命的情况,因为其病程伴有急性靶器官损害,病情复杂。它们可表现为神经、肾脏、心血管、微血管病性溶血性贫血及产科并发症。诊断后,需要在重症监护病房使用硝普钠等静脉药物在1小时内迅速降低血压(<1小时)。这些患者的平均动脉压>140 mmHg,伴有III至IV级视网膜病变。仅偶尔会出现高血压脑病,反映出脑血流灌注过多、自身调节功能丧失及血脑屏障破坏。在高血压急症中,血压应在第1小时内降低约10%,并在接下来的2至3小时内再逐渐降低15%,以防止脑灌注不足。这种管理策略的例外情况是主动脉夹层,对此目标是在20分钟后使收缩压<120 mmHg。通常在肠外治疗6至12小时后可开始口服抗高血压治疗。高血压亚急症是血压严重升高但无急性和进行性靶器官功能障碍的证据。它们需要在24小时至数天内使用口服药物充分控制血压。本综述的目的是提供一种合理的高血压危象管理方法。

相似文献

1
Management of hypertensive crises.高血压急症的管理
Am J Ther. 2007 Mar-Apr;14(2):135-9. doi: 10.1097/01.pap.0000249908.55361.de.
2
[Hypertensive emergency and urgence].[高血压急症与亚急症]
Herz. 2003 Dec;28(8):717-24. doi: 10.1007/s00059-003-2506-8.
3
Clinical features in the management of selected hypertensive emergencies.特定高血压急症管理中的临床特征。
Prog Cardiovasc Dis. 2006 Mar-Apr;48(5):316-25. doi: 10.1016/j.pcad.2006.02.004.
4
[Hypertensive crises. 2. Treatment].[高血压危象。2. 治疗]
Ugeskr Laeger. 1995 Dec 18;157(51):7140-5.
5
Hypertension crisis.高血压危象
Blood Press. 2010 Dec;19(6):328-36. doi: 10.3109/08037051.2010.488052. Epub 2010 May 27.
6
The diagnosis and treatment of hypertensive crises.高血压急症的诊断与治疗
Postgrad Med. 2009 Jan;121(1):5-13. doi: 10.3810/pgm.2009.01.1950.
7
The management of hypertensive crises: a clinical review.高血压急症的管理:一项临床综述。
Clin Ter. 2009;160(2):151-7.
8
Hypertensive crises. The need for urgent management.高血压急症。紧急处理的必要性。
Postgrad Med. 1996 Jan;99(1):189-91, 195-6, 199-200, passim.
9
[Hypertensive emergency].[高血压急症]
Praxis (Bern 1994). 2001 Nov 15;90(46):2009-14.
10
Hypertensive crises: diagnosis and management in the emergency room.高血压急症:急诊室的诊断与处理
Eur Rev Med Pharmacol Sci. 2004 Jul-Aug;8(4):143-52.

引用本文的文献

1
Acute Cerebrovascular Accident, Renal Failure, and Thrombotic Microangiopathy in a 27-Year-Old Male With Malignant Hypertension.一名27岁恶性高血压男性患者的急性脑血管意外、肾衰竭和血栓性微血管病
Clin Case Rep. 2025 Jun 16;13(6):e70565. doi: 10.1002/ccr3.70565. eCollection 2025 Jun.
2
Cerebral hypoperfusion due to rapid blood pressure control in a patient with type B aortic dissection: A case report.B型主动脉夹层患者因血压快速控制导致脑灌注不足:一例报告
SAGE Open Med Case Rep. 2025 Feb 10;13:2050313X251316985. doi: 10.1177/2050313X251316985. eCollection 2025.
3
A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths.
重新评估单胺氧化酶抑制剂的安全性概况:阐明陈旧的酪胺神话。
J Neural Transm (Vienna). 2018 Nov;125(11):1707-1717. doi: 10.1007/s00702-018-1932-y. Epub 2018 Sep 25.
4
Emergency Room Treatment of Hypertensive Crises.高血压急症的急诊治疗
Med Arch. 2015 Oct;69(5):302-6. doi: 10.5455/medarh.2015.69.302-306. Epub 2015 Oct 4.
5
Pharmacokinetics and tissue distribution of clevidipine and its metabolite in dogs and rats.氯维地平及其代谢产物在犬和大鼠体内的药代动力学及组织分布
J Huazhong Univ Sci Technolog Med Sci. 2014 Dec;34(6):856-860. doi: 10.1007/s11596-014-1364-3. Epub 2014 Dec 6.
6
Clinical presentation of hypertensive crises in emergency medical services.急诊医疗服务中高血压急症的临床表现。
Mater Sociomed. 2014 Feb;26(1):12-6. doi: 10.5455/msm.2014.26.12-16. Epub 2014 Feb 20.
7
Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial.静脉用尼卡地平与拉贝洛尔在急诊科有靶器官损害迹象或症状的高血压患者中的应用:CLUE 试验的亚组分析。
BMJ Open. 2013 Mar 26;3(3):e002338. doi: 10.1136/bmjopen-2012-002338.
8
Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension.轻中度原发性高血压患者中长时间持续输注后拉贝洛尔的药代动力学、药效学和安全性。
Eur J Clin Pharmacol. 2012 Oct;68(10):1385-94. doi: 10.1007/s00228-012-1260-3. Epub 2012 Mar 29.
9
Drug treatment of hypertensive crisis in children.儿童高血压危象的药物治疗。
Paediatr Drugs. 2011 Oct 1;13(5):281-90. doi: 10.2165/11592130-000000000-00000.
10
Attitudes and practices of resident physicians regarding hypertension in the inpatient setting.住院医师在住院环境中对高血压的态度和实践。
J Clin Hypertens (Greenwich). 2010 Sep;12(9):698-705. doi: 10.1111/j.1751-7176.2010.00309.x.